Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue		$ 1,260,000
Operating expenses:
Research and development (net of collaboration funding of $7,825,263 and $6,055,295 in the years ended December 2022 and 2021, respectively)	$ 11,924,837	6,508,055
General and administrative (net of collaboration funding of $8,248,813 and $3,197,659 in the years ended December 2022 and 2021, respectively)	12,689,422	10,700,334
Total operating expenses	24,614,259	17,208,389
Loss from operations	(24,614,259)	(15,948,389)
Other income (expense), net:
Costs of debt issuance	(1,720,094)
Changes in fair value of debt instruments gain (loss)	245,138
Interest and other income (expense), net	(101,432)	519,639
Foreign currency transaction gain (loss)	(46,668)	54,757
Total other income (expense), net	(1,623,056)	574,396
Net loss	$ (26,237,315)	$ (15,373,993)
Net loss per share - basic	$ (1.66)	$ (1.08)
Weighted average common shares outstanding - basic	15,767,152	14,268,245
Net loss per share - diluted	$ (1.66)	$ (1.08)
Weighted average common shares outstanding - diluted	15,767,152	14,268,245